AAV case study: 3X titer with integrated clarification
Two case studies illustrate multi-fold upstream AAV titer increases for viral vector from HEK293 cells. In addition to productivity gains, XCell™ and TFDF® technologies clarify conditioned media for manufacturing operational simplicity. Product yield and process economics in the context of the current viral vector supply demand gap will be discussed.
Nov 01, 2021
Discover More Webinars
Webinar
Turbocharging pDNA Production: CDMO Case Study in Optimization
May 26
Webinar
Automating the UF/DF Process with In-Line Concentration Measurement to Reduce Cycling Time and Accelerate PD
May 8
Webinar
Innovative, differentiated technologies advancing new modalities: Case studies in mRNA & viral vectors
Feb 23
Webinar
Strategic considerations to future-proof single-use assemblies
Feb 16
Webinar
Accelerate your UF/DF process using the only in-line concentration controlled TFF system
Feb 9
